Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples